ALX Oncology Holdings Inc (ALXO)
15.36
-1.26
(-7.58%)
USD |
NASDAQ |
May 03, 16:00
15.36
0.00 (0.00%)
After-Hours: 19:09
ALX Oncology Holdings Net Income (TTM): -160.80M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -160.80M |
| September 30, 2023 | -146.04M |
| June 30, 2023 | -130.37M |
| March 31, 2023 | -129.13M |
| December 31, 2022 | -123.48M |
| September 30, 2022 | -121.21M |
| June 30, 2022 | -110.46M |
| March 31, 2022 | -93.81M |
| December 31, 2021 | -83.46M |
| Date | Value |
|---|---|
| September 30, 2021 | -73.80M |
| June 30, 2021 | -59.41M |
| March 31, 2021 | -54.47M |
| December 31, 2020 | -45.74M |
| September 30, 2020 | -34.73M |
| June 30, 2020 | -27.59M |
| March 31, 2020 | -20.46M |
| December 31, 2019 | -19.24M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-160.80M
Minimum
Dec 2023
-19.24M
Maximum
Dec 2019
-84.37M
Average
-83.46M
Median
Dec 2021
Net Income (TTM) Benchmarks
| Bristol-Myers Squibb Co | -6.148B |
| Nurix Therapeutics Inc | -144.73M |
| Exelixis Inc | 205.05M |
| Geron Corp | -184.13M |
| Verastem Inc | -87.37M |